APPLICATIONS PUBLISHED 12 FEBRUARY 2003
Published: 1-Aug-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
External application for enhancing the skin permeability of the active components therein
Pacific Corp 1282393*
Use of N,N'-dibenzyl ethylene diamine as anti-pollution agent
L'Oreal 1282394*
Use of ellagic acid as anti-pollution cosmetic agent
L'Oreal 1282395*
Anti-pollution compsns based on anthocyanic pigments
L'Oreal 1282396*
Inhalation therapy decongestant with foraminous carrier
Lec Tec Corp 1282398*
Rapidly disintegrating solid oral dosage form
Elan Pharma International 1282399*
Pharmaceutical form of administration for peptides, methods for its production and use
Zentaris 1282400*
Stabilised steroidal suspension
Pharmacia & Upjohn 1282401*
Stabilised aqueous suspensions for parenteral use
Pharmacia Italia 1282402*
Non-invasive gene targeting to the brain
The Regents of the University of California 1282403*
Method for preparing microparticles having a selected polymer molecular weight
Alkermes Controlled Therapeutics 1282404*
Stable metal ion-lipid powdered pharmaceutical compsns for drug delivery and methods of use
Alliance Pharmaceuticals 1282405*
Pharmaceutical kit comprising midodrine as an active drug substance
Nycomed Austria 1282406*
Delivery mechanism for the introduction of biological substances to animals
Agresearch 1282407*
Hydrogel compsn for transdermal drug delivery
Samyang Corp 1282408*
Insulin formulation for inhalation
Elan Drug Delivery 1282409*
Novel medical use of aldosterone synthase inhibitors alone or in combination with AT1-receptor antagonists
Novartis 1280410*
Method of treating cancer
Charlotte-Mecklenburg Hospital Authority doing business as Carolinas Medical Centre 1282411*
Treating irritable bowel syndrome or disease
Meracol Corp 1282412*
Halogenated 2-amino-5,6-heptenoic acid derivatives useful as nitric oxide synthase inhibitors
Pharmacia 1282413*
Felbamate derived compounds
University of West Virginia Patent Foundation; MacDonald, Timothy 1282414*
Compounds and methods for regulating bacterial growth and pathogenesis
Princeton University; Quorex Pharmaceuticals; University Technologies International 1282415*
Dehydroascorbic acid formulations and uses thereof
Progenics Pharmaceuticals 1282416*
Creatinine biosensor
F Hoffmann-La Roche 1282417*
Use of pyrazole derivatives for treating infertility
Serono Reproductive Biology Institute 1282418*
Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
Bristol-Myers Squibb 1282419*
Halogenated 2-amino-3, 4-heptenoic acid derivatives useful as nitric oxide synthase inhibitors
Pharmacia 1282420*
Use of NGF-antagonists for the prevention or treatment of chronic visceral pain
Warner-Lambert 1282421*
Ciplofloxacin infusion solutions with improved storage life
Fresenius Kabi Deutschland 1282422*
Prevention of insulin-dependent diabetes, complications thereof, or allograft rejection by inhibition of cyclooxygenase-2 activity with NS398 or PDTC
Oklahoma Medical Research Foundation 1282423*
Compsns for enhancing the immune response
Bioenergy; University of Florida Research Foundation 1282424*
Crystal structures of P-selectin, P- and E-selectin complexes, and uses thereof
Genetics Institute 1282425*
Nutritional preparation comprising ribose and folic acid and medical use thereof
NV Nutricia 1282426*
Immunostimulatory polynucleotide sequences for use in suppressing hepatitis virus infection
Dynavax Technologies 1282427*
Biocompatible macromers
Wm Marsh Rice University 1282428*
Pharmaceutical gel compsn
Chiltern Pharmaceuticals 1282429*
Immune response modulation
Porter, William Leslie 1282430*
Phytotherapeutic compsn for preventing cardiovascular diseases
Dervieux, Dominique 1282431*
Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
University of Maryland, Baltimore 1282432*
Transgenically produced decorin
Genzyme Transgenics 1282433*
Method for cell adhesion and wound healing
Regen Biotech 1282434*
Interleukin-1 inhibitors in the treatment of diseases
Immunex Corp 1282435*
Treatment of acute coronary syndrome with GLP-1
Bionebraska 1282436*
Method for treating cartilage disorders
Genentech 1282437*
Pharmaceutical compsn comprising a factor VIIA and a factor XIII
Novo Nordisk 1282438*
Pharmaceutical compsn comprising a factor VIIA and a TFPI inhibitor
Novo Nordisk 1282439*
Aromatase inhibitors and monoclonal anti-HER2 antibodies as anti-tumour agents
Pharmacia Italia; Pharmacia & Upjohn 1282440*
Treating T-cell modulated diseases by modulating DR6 activity
Eli Lilly 1282441*
Cancer treatments by using a combination of an antibody against HER2 and interleukin-2
Health Research; Arch Development Corp 1282442*
Gene detection assay for improving the likelihood of an effective response to an ERBB antagonist cancer therapy
Genentech 1282443*
Antithrombitic agents
SmithKline Beecham 1282444*
N-substituted dithiocarbamates for the treatment of biological disorders
Atherogenics 1282445*
Pharmaceutical and/or cosmetic compsn containing an organosiloxane and a phospholipid
MIKA Pharma Gesellschaft fuer die Entwicklung und Vermarktung pharmazeutisher Produkte 1282446*
Stable polymeric micelle-type drug compsn and method for the preparation thereof
Samyang Corp 1282447*
Heterobifunctional cross-linking agent conjugate substituted by an immunomodulator and cell recognition unit
Gluesenkamp, Karl-Heinz; Dilloo, Dagmar 1282448*
Treatment of human papillomavirus (HPV)-infected cells
The Regents of the University of California 1282449*
